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Central to the biology of many pathogenic bacteria are a number of specialized machines, known as type III,
type IV, or type VI protein secretion systems. These machines have specifically evolved to deliver bacterial
effector proteins into host cells with the capacity to modulate a variety of cellular functions. The identification
of the biochemical activities of many effector proteins, coupled with a better understanding of their potential
contribution to pathogenesis, has revealed common themes in the evolutionary design and function of these
remarkable bacterial proteins.Introduction
Many gram-negative bacteria that are pathogenic or symbiotic
for plants, insects, or animals have evolved complex machines
to transfer multiple bacterially encoded proteins into eukaryotic
cells. At least three different types of these machines, which
for historical reasons are referred to as type III, type IV, and
type VI protein secretion systems, have been described (Christie
et al., 2005; Filloux et al., 2008; Gala´n and Wolf-Watz, 2006). A
great deal of attention has been devoted to the study of these
machines, because they are central to the pathogenesis of the
bacterial pathogens that encode them. Proteins delivered by
these machines have the capacity to modulate a variety of
cellular functions and are collectively known as effectors. Effec-
tors are distinct from bacterial toxins, which are also bacterial
products that exert their function on living cells or organisms
(Alouf, 2000). A unique property of toxins is that their toxic effects
can be observed when exogenously added to living organisms or
cells. In contrast, the term ‘‘effectors’’ should be reserved for
molecules that require specialized multiprotein machines for
their direct delivery into target cells. However, the distinction
between toxins and effectors reflects more than just differences
in their delivery mechanisms. Bacterial toxins usually have
a single biochemical activity that directly exerts its effect on
specific cellular targets. By contrast, effector proteins exert their
specific function in concert with the activities of multiple other
bacterial effectors delivered by the same machine. The activities
of effector proteins are often subtle and more ‘‘tuned’’ to modu-
late cellular functions rather than to irreversibly disrupt cellular
homeostasis. In fact, the evolution of protein delivery machines
such as type III, type IV, and type VI secretion systems may
have been specifically driven by the need to deliver multiple
proteins in a coordinated fashion to modulate complex cellular
processes.
The study of effector proteins delivered by these specialized
machines has provided remarkable insight not only into funda-
mental aspects of host/pathogen interactions, but also into the
basic biology of eukaryotic cells. Despite the diversity of activi-
ties associated with the different effector proteins, it is now
evident that there are a number of common themes that charac-
terize the function of these molecules. The common themes in
the evolutionary design of these molecules will be the subjectof this review. In addition, the significant challenges to the study
of these effector proteins stemming from their unique properties
will also be discussed. In discussing these general themes, I will
be drawing from specific examples of effectors delivered by type
III secretion systems (T3SSs), since they are the best character-
ized. However, I believe that these principles are applicable to
bacterial effector proteins delivered by other machines. The
purpose of this article is not to comprehensively review the liter-
ature of T3SSs or bacterial effector proteins. Rather, the intent is
to discuss a limited set of specific examples of T3SS effectors
that best illustrate the existence of common principles in the
design and function of bacterial effector proteins.
Mimicry of Host Cell Proteins
T3SSs are encoded by many important pathogenic bacteria,
including Salmonella enterica serovars (e.g., S. Typhimurium,
S. Typhi, etc.), Shigella spp., Yersinia spp., Chlamydia spp.,
Pseudomonas spp., Vibrio spp.,Bordetella spp., and pathogenic
strains of E. coli (Gala´n and Wolf-Watz, 2006). All of these
bacteria have evolved complex and unique functional interfaces
with eukaryotic cells, and their T3SSs are central components of
these interfaces. A theme that has emerged over the last few
years is that many T3SS effector proteins exert their function
by mimicking activities of endogenous cellular proteins (Steb-
bins and Gala´n, 2001). Such mimicry can sometimes be de-
tected at the level of the primary amino acid sequence. For
example, some effectors share significant amino acid sequence
similarity to eukaryotic cell proteins (e.g., protein kinases or
phosphatases) (Galyov et al., 1993; Guan and Dixon, 1990).
Therefore, their potential biochemical activities can be simply
predicted from primary amino acid sequence analysis, although
the identification of the cellular targets of these activities most
often requires specific experimentation. However, this straight-
forward mimicry is rarely observed among most bacterial effec-
tors. In fact, many effectors faithfully mimic the activities of
cellular proteins without detectable amino acid sequence simi-
larity (Stebbins and Gala´n, 2001). In such cases, the activities
of the effector proteins cannot be predicted from their amino
acid sequence analysis or even from their proto atomic struc-
tures (i.e., the atomic structures of the effector proteins by them-
selves and not in complex with their targets). For example, someCell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc. 571
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(A) S. Typhimurium SopE mimics Rho family GEFs. The conformational changes induced on the G domain of Cdc42 by SopE (shown in green) are similar to those
induced by mammalian exchange factor Tiam1 on Rac1 (shown in gray). The P loop, switch I/II regions are shown for the individual molecules. Relevant regions of
SopE and Tiam1 are shown in red and blue, respectively. The view shows the similar location of the catalytic loop from SopE and the important Lys1195 from Tiam
(taken from Buchwald et al., 2002).
(B) S. Typhimurium SptP mimics Rho family GAPs. The active sites of three transition-state complexes between small GTPases (Rac1, Cdc42, and Ras) and their
cognate GAPs (SptP, Cdc42 GAP, and Ras GAP) depicting the nucleotide and catalytic arginine present in all known GAPs are shown. This image illustrates that
despite using a similar chemistry to the host factors, SptP (in blue) presents the arginine from a completely different protein architecture. AlFX, aluminum fluoride
(taken from Stebbins and Gala´n, 2001).
(C) Effector proteins mimic three different types of E3 ligases. Shown are the E3 ligase domains of S. Typhimurium SspH2, showing the NEL domain; S. Typhi-
murium SopA, a HECT family of cysteine-dependent E3 ubiquitin ligases from Salmonella; and AvrPtoB, a RING finger/U-box protein. The catalytic cysteine resi-
dues are shown in a space-filling format colored blue (taken from Quezada et al., 2009).effector proteins target Rho family GTPases by mimicking the
activities of guanine nucleotide exchange factors (GEFs) or
GTPase-activating proteins (GAPs). Yet there is nothing in their
primary amino acid sequence that would suggest these activi-
ties. Such is the case for the S. Typhimurium T3SS effectors
SopE and SptP, which are a GEF and a GAP, respectively, for
Rac, Cdc42, and RhoG (Fu and Gala´n, 1999; Hardt et al.,
1998a). The crystal structure of the effector/target protein
complex shows conformational changes imposed by SopE on
the nucleotide-binding region of Rac1 that are virtually identical
to those imposed by an endogenous exchange factor such as
Tiam1 (Figure 1A) (Buchwald et al., 2002). However, to introduce
those conformational changes on its targets, which are critical
for the nucleotide exchange activity, SopE utilizes different
chemistry than Tiam1. This finding indicates that, remarkably,
evolution has found more than one mechanism to execute
essentially the same biochemical activity. Likewise, the crystal572 Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc.structure of SptP alone does not suggest that it would have
GAP activity. However, when viewed in complex with its target,
its GAP activity can be clearly inferred (Figure 1B) (Stebbins
and Gala´n, 2000). In this case, however, SptP utilizes chemistry
similar to that utilized by most eukaryotic cell GAPs, which
involves the precise positioning of a critical arginine residue
within the active site of the GTPase. Therefore, SopE and SptP
can be considered ‘‘convergently evolved’’ mimics of their eu-
karyotic cell counterparts.
Other examples of mimicry to modulate Rho family GTPase
function are even more subtle. For example, the E. coli T3SS
effector EspF(U) mimics an autoinhibitory domain found within
N-WASP (Cheng et al., 2008). Through this mimicry, EspF(U)
activates N-WASP by competitively disrupting its autoinhibited
state. In this sense, EspF(U) functionally mimics Cdc42, which
activates N-WASP in a similar manner. Another example of
subtle mimicry is a group of T3SS effectors, collectively known
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Effector protein Bacteria Mimicry Phenotype References
SopE Salmonella enterica GEF for Rho family
GTPases
Bacterial entry into
nonphagocytic cells
Hardt et al., 1998b
SptP (N terminus);
YopE/ExoS (N terminus)
Salmonella
enterica;Yersinia spp./
Pseudomonas
aeruginosa
GAP for Rho family
GTPases
Recovery of the actin
cytoskeleton after bacterial
internalization (SptP); disruption
of the actin cytoskeleton
(YopE and ExoS)
Fu and Gala´n, 1999; Von
Pawel-Rammingen et al.,
2000; Goehring et al., 1999
SopA Salmonella enterica HECT-like E3
ubiquitin ligase
Promotes inflammation Diao et al., 2008
SseL Salmonella enterica Ubiquitin protease Macrophage killing Rytko¨nen et al., 2007
SspH and IpaH family
members
Salmonella enterica
and Shigella spp.
E3 ubiquitin ligase Unknown Rohde et al., 2007
SopB/IpgD Salmonella enterica
and Shigella spp.
Phosphoinositide
phosphatases
Stimulation of SGEF, modulation
of vesicular trafficking, Akt
activation (SopB); PI3 Kinase
activation (IpgB)
Patel and Gala´n, 2006;
Hernandez et al., 2004;
Steele-Mortimer et al., 2000
XopD (several family
members)
Xanthomonas
campestris
Cysteine protease
for SUMO
Disruption of plant defense
response
Hotson et al., 2003
IpgB/SifA and other
family members
Shigella spp. and
Salmonella enterica
Activated Rho family
GTPases
Modulation of the actin
cytoskeleton (IpgB); endosomal
tubulation (SifA)
Alto et al., 2006; Ohlson
et al., 2008
EspF/TccP2 E. coli N-WASP autoinhibitory
domain
Actin nucleation at the plasma
membrane
Cheng et al., 2008
IpaA Shigella spp. Vinculin Actin reorganization and
bacterial internalization into
nonphagocytic cells
Izard et al., 2006
AvrPtoB and family
members
Pseudomonas
syringae
RING-like E3 ubiquitin
ligase
Inhibition of programmed cell
death
Janjusevic et al., 2006
GALA family of proteins Ralstonia solanacearum F-box proteins Promotes virulence Angot et al., 2006
VopF Vibrio cholerae Formins/spire Promotes actin nucleation Tam et al., 2007as the WxxxE family of effector proteins, which include the
Shigella spp. effectors IpgB1 and IpgB2 and the S. Typhimurium
effector SifA. These effectors trigger responses equivalent to
those stimulated by activated Rho family GTPases by mimicking
the activated state of these small G proteins, and recent struc-
tural studies reveal that although there is no primary sequence
similarity, they are structural mimics of bacterial GEFs such as
SopE (Alto et al., 2006; Ohlson et al., 2008).
Other examples of mimicry are seen in T3SS effectors that
target the ubiquitination machinery. Protein ubiquitination is
a multistep enzymatic process that results in the addition of
ubiquitin to internal lysine residues of the substrate protein
(Glickman and Ciechanover, 2002). The process involves an
ubiquitin-activating enzyme (E1), which transfers ubiquitin to
a family of ubiquitin-conjugating enzymes (E2s). Ubiquitin-
loaded E2s are then recruited to their substrates by a family of
ubiquitin ligases (E3s), which play a critical role in substrate
recognition. Some T3SS effectors, exemplified by S. Typhimu-
rium SopA or Pseudomonas syringae AvrPtoB, mimic the
HECT- and RING-domain type of E3 ubiquitin ligases, respec-
tively (Figure 1C) (Diao et al., 2008; Janjusevic et al., 2006). In
contrast, a recently identified family of T3SS effector proteins
with E3 ligase activity mimics the cysteine-based chemistry of
HECT E3 ligases but shares no structural similarity to any knowneukaryotic cell E3 ligases (Figure 1C) (Quezada et al., 2009;
Singer et al., 2008; Zhu et al., 2008).
From the examples discussed here and others listed in Table 1,
it is apparent that mimicry is emerging as one of the most
common features in the function of T3SS effector proteins. In
the context of the biology of most bacteria-encoding T3SSs,
mimicry appears to be a very suitable strategy to interact with
the host, because it usually leads to reversible modulation of
cellular functions without overt harm to the target cell. Since
this mimicry most often cannot be gleaned from the primary
amino acid sequence or even from the proto crystal structures
of the effectors, a number of bioinformatics or high-throughput
crystallographic approaches are of limited use in the study of
T3SS effector proteins. Rather, in most cases, the identification
of their specific targets or even the solution of the atomic struc-
tures of the effector/target protein complexes is required to char-
acterize their function.
Covalent Modifications of Host Cell Proteins
A number of effector proteins exert their function by introducing
covalent modification to target cellular proteins (Table 2). In
some instances, these covalent modifications are reversible
and presumably aimed at modulating cellular functions by tran-
siently altering the activity of the cellular targets. PhosphorylationCell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc. 573
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Effector protein Bacteria Covalent modification Targets References
YopH/SptP (C terminus) Yersinia spp. and
Salmonella enterica
Protein tyrosine
phosphatase
Many Guan and Dixon, 1990;
Kaniga et al., 1996
YpkA/OspG Yersinia spp. andShigella
spp.
Serine/threonine protein
kinase
Gaq subunit of heterotrimeric
G proteins (YpkA); ubiquitin-
conjugating enzymes (OspG)
Navarro et al., 2007;
Kim et al., 2005
YopJ/AvrA and other
family members
Yersinia spp. and
Salmonella enterica
Acetylation MAP kinase kinases Mukherjee et al., 2006;
Jones et al., 2008
OspF/SpvC Shigella spp. and
Salmonella enterica
Phosphothreonine lyase MAP kinases Li et al., 2007
ExoS/ExoT (C terminus)1 Pseudomonas
aeruginosa
ADP ribosylation Many Barbieri, 2000
VopS Vibrio parahaemolyticus AMPylation Rho family GTPases Yarbrough et al., 2009is one of the most common mechanisms of signal transduction
utilized by eukaryotic cells. It is therefore not surprising that
several T3SS effectors target this process to modulate cell func-
tion. For example, serine/threonine protein kinases have been
identified in Shigella spp. (e.g., OspG) (Kim et al., 2005) and
Yersinia spp. (e.g., YpkA/YopO) (Galyov et al., 1993). The
Shigella OspG effector phosphorylates host ubiquitin-conju-
gating enzymes to thwart innate immune responses (Kim et al.,
2005). The Yersinia YpkA/YopO kinase phosphorylates Gaq,
thus inhibiting G protein-coupled receptor signaling (Navarro
et al., 2007), although the significance of this activity for Yersinia
spp. pathogenesis is unknown. In addition, several effectors with
protein phosphatase activity have also been identified. This
includes the Yersinia YopH andSalmonella SptP effectors, which
disrupt macrophage function and MAP kinase signaling, respec-
tively, by targeting several tyrosine-phosphorylated cellular
proteins (Bliska and Black, 1995; Murli et al., 2001).
More recently, several effector proteins with enzymatic activ-
ities resulting in unusual covalent modification have been
discovered. For example, a family of T3SS effectors, which
includes the Shigella spp. OspF and Salmonella SpvC proteins,
was shown to inhibit MAP kinase signaling by an unusual post-
translational modification. This modification involves a phospho-
threonine lyase enzymatic activity, which results in the irrevers-
ible removal of the phosphate group from phosphothreonine
and its conversion into dehydrobutyrine (Li et al., 2007). This
activity has not yet been described in eukaryotic cells. Another
example of an unusual covalent modification associated with
an effector is the Yersinia YopJ protein, which inhibits various
signal-transduction pathways by acetylating critical serine or
threonine residues of a group of proteins belonging to the MAP
kinase kinases (MKK) family (Mukherjee et al., 2006). Since the
MKKs are activated by phosphorylation of the same residues tar-
geted by YopJ, the modified kinases cannot be activated.
Protein acetylation is a well-characterized regulatory mechanism
of eukaryotic cell histones. However, histone acetyl transferases
in eukaryotic cells modify protein function by acetylating lysine
residues. Therefore, YopJ is the first identified enzyme that acet-
ylates serine and threonine residues, and it has been suggested
that YopJ may well mimic a yet-to-be-identified class of eukary-
otic enzymes that may regulate signaling via acetylation. Another
unusual covalent modification mediated by the T3SS effector574 Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc.protein VopS has been described in Vibrio parahaemolyticus
(Yarbrough et al., 2009). This effector covalently modifies
a conserved threonine residue on Rho, Rac, and Cdc42 by add-
ing adenosine 50-monophosphate (AMP), a process that has
been referred to as ‘‘AMPylation.’’ AMPylated Rho GTPases
are unable to interact with downstream effectors, thereby inhib-
iting actin dynamics in the infected cell. Interestingly, AMPylated
proteins have also been detected in eukaryotic proteins in the
absence of bacterial infection. Although it is still unclear whether
these modifications are reversible, the finding of acetylated
and AMPylated proteins within the host cell suggests that this
may well be the case and that these posttranslational modifica-
tions may be involved in cell signaling. These examples of novel
activities associated with T3S effectors that may be present in
eukaryotic cells showcase how the study of bacterial virulence
factors may lead to important new insights into basic cell
biology.
Work in Concert with Other Effector Proteins
One of the most daunting challenges in the study of T3SS
effector proteins is the fact that they exert their function in the
context of other effector proteins. Indeed, it can be argued
that, in contrast to toxins (as defined above), T3SSs have
evolved to modulate complex cellular functions in a manner that
requires the coordinated activity of many effectors delivered
in a precise temporal and spatial manner. For example, the
Salmonella T3SS effector SptP is a GAP for several Rho-GTPase
family members (Fu and Gala´n, 1999). Since one of the physio-
logical roles of these small G proteins is to modulate actin
dynamics, transient expression of SptP into mammalian cells
leads to a profound change in the actin cytoskeleton. This obser-
vation led to the erroneous conclusion that the function of this
effector was to disrupt the actin cytoskeleton, presumably to
prevent phagocytosis (Fu and Gala´n, 1998). However, subse-
quent studies showed that the function of SptP was indeed the
opposite. In the context of other Salmonella effectors that have
the capacity to activate Rho family GTPases (e.g., the GEFs
SopE and SopE2), the SptP GAP activity is required for the cells
to recover homeostasis (Fu and Gala´n, 1999). Since profuse
stimulation of Rho family GTPases by the bacterial effectors is
harmful to the cell, Salmonella evolved an effector to put
a ‘‘brake’’ to such stimulation and thus preserve the integrity of
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tionist approaches commonly utilized in the field to study
effector function (e.g., overexpression of single effectors within
a cell) can lead to misinterpretation. To compound the challenge,
T3SS effectors are usually delivered in very small amounts,
which is in sharp contrast with many experimental approaches
that result in a vast overexpression of a given effector within
cells. Therefore, while the biochemical activities of many of
T3SS effectors are known, the main challenge remains to identify
their relevant cellular targets. In this regard, it will be essential to
consider both the environment in which these effectors exert
their function and the concentration that they achieve within
the cell during infection. Once these parameters are considered,
it is possible that some of the targets that have thus far been
identified using standard approaches may prove to be irrelevant.
Similar Biochemical Activity in a Different Bacteria/Host
Interface Results in Unique Effects
During the last few years, remarkable progress has been made in
the identification of enzymatic activities associated with T3SS
effector proteins, many of them discussed in this article.
However, there has been much less progress in the under-
standing of the contribution of these activities to the host/path-
ogen interactions. Although the identification of the biochemical
activity of a given effector is very helpful, it is certainly not suffi-
cient to understand its potential role during infection. The identi-
fication of the physiological targets of those activities is essential
to really understand effector function in the context of infection.
As discussed above, T3SSs are central components of the host/
pathogen interface. Given the great diversity in the pathogens
that encode T3SS, the host/pathogen functional interface in
which these systems participate varies considerably. Yet appar-
ently homologous effectors (i.e., effectors with the same
biochemical activities) are encoded by very different pathogens.
The differences between host/pathogen functional interfaces
must be considered before extrapolating findings from homolo-
gous effectors encoded by different pathogens, since it is
possible that the same biochemical activity associated with
such an effector may be directed to a different target or may
result in a different effect. For example, some of these pathogens
have evolved to gain access into host cells while others remain
extracellular during their infection cycle. Salmonella spp. and
Yersinia spp. are intracellular and extracellular pathogens,
respectively, and yet they encode several apparently homolo-
gous effectors. Yersinia YopE and Salmonella SptP are both
GAPs for Rho family GTPases (Fu and Gala´n, 1999; Von
Pawel-Rammingen et al., 2000). Yet while YopE disrupts the
actin cytoskeleton to prevent bacterial phagocytosis, SptP, as
discussed above, counters the activity of other effectors to
restore cellular homeostasis and the integrity of the actin cyto-
skeleton. The acetyl transferases YopJ and AvrA encoded by
Yersinia spp. and S. Typhimurium are another example of appar-
ently homologous effectors carrying out different functions.
While YopJ broadly inhibits all MAP kinase pathways and
NF-kB signaling by targeting all MKKs and IKKb (Orth, 2002),
AvrA, when delivered in physiological amounts into eukaryotic
cells, only targets the Jnk pathway (Jones et al., 2008; F. Du
and J.G., unpublished data). Therefore, it seems that evolution
has shaped the activity of these highly related molecules tosuit the functional interface of the respective pathogens that
harbor them. In the case of Yersinia spp., an extracellular path-
ogen, YopJ has evolved to broadly inhibit the host innate
immune response. In contrast, AvrA exerts a more subtle effect
to presumably modulate but not prevent the transcriptional
responses induced by Salmonella. The take-home message of
this common theme is that the context in which a given effector
exerts its activity is crucial for the understanding of its function
during infection.
Precise Temporal Regulation
As discussed above, the function of different effectors delivered
by the same pathogen is exerted in the context of the activities of
other effectors, ultimately resulting in the modulation or induction
of highly coordinated and complex cellular responses. There-
fore, it is not surprising that the specific activity of individual
effectors is highly regulated both temporally and spatially. There
are several mechanisms involved in the temporal regulation of
T3SS effector function. For example, although poorly under-
stood at the mechanistic level, there is increasing evidence
that there is a hierarchy in the engagement of T3SS effectors
by the protein delivery machine (Collazo and Gala´n, 1996;
Deng et al., 2005; Sorg et al., 2006; Wang et al., 2008). It is there-
fore possible that this mechanism may be central for the
temporal coordination of the delivery of groups of effector
proteins, particularly if these effectors must be delivered in a hier-
archical fashion over a short period of time.
In addition, some pathogens encode more than one T3SS that
are expressed at different times during infection and are able to
recognize and deliver different effector proteins, whose expres-
sion is also temporally regulated. This may afford the pathogen
the opportunity to temporally coordinate the delivery of groups
of effector proteins that must exert their function at different
times during infection. This is certainly the case in Salmonella
enterica, which encodes two T3SSs in its pathogenicity islands
1 (SPI-1) and 2 (SPI-2) (Gala´n, 2001). The SPI-1 T3SS is ex-
pressed during Salmonella’s extracellular stage, while expres-
sion of SPI-2 is induced after internalization. Consequently, the
SPI-1 T3SS mediates entry into cells (and the stimulation of tran-
scriptional responses), while the SPI-2 mediates the sculpting of
a specific intracellular niche that allows Salmonella to replicate.
Each one of these T3SSs recognizes specific effector proteins,
and consequently, it has been traditionally assumed that they
exert their function in an independent manner. However, it is
becoming increasingly clear that there is a much closer func-
tional relationship between these two systems than originally
thought. For example, in addition to mediating entry, the SPI-1
T3SS effector proteins divert the S. enterica-containing phago-
some from being delivered into lysosomes (Hernandez et al.,
2004; Steele-Mortimer et al., 2002). This in turn allows the
expression of effectors of the SPI-2 T3SS, which further modu-
late vesicular trafficking to establish the final replicative niche.
In addition, it is becoming clear that some of the T3SS effectors
can be recognized by both T3SSs (Miao et al., 1999). Therefore, it
appears that ‘‘hierarchy’’ alone may not be sufficient to tempo-
rally coordinate the delivery of many effectors that exert their
function in a coordinate manner at different times over the infec-
tion cycle. Consequently, it seems that Salmonella has evolvedCell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc. 575
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delivery of these effectors.
Yet another mechanism of temporal regulation involves the
specific half-life of the effectors within the target cell. For
example, as discussed above, the Salmonella T3SS effectors
SopE and SptP possess opposite activities (GEF and GAP for
the same Rho family GTPases, respectively), and yet they seem
to be delivered into cells roughly at the same time. However, their
half-lives within cells are quite different. While SopE is rapidly
degraded by an ubiquitin-mediated process shortly after its
delivery, SptP remains within cells for an extended period of
time (Kubori and Gala´n, 2003). Finally, many bacterial pathogens
encode E3 ubiquitin ligases, whose targets are unknown (Angot
et al., 2007). It is possible that some of these enzymes may be
involved in the temporal regulation of the activity of effector
proteins delivered by the same T3SS.
Precise Localization and Functional Diversification
It is increasingly clear that effector proteins exert their function at
precise locations within the cells, which is central to their func-
tion. Yet remarkably little is known about the mechanisms that
restrict the location of an effector to a given compartment. This
is, in part, due to the experimental difficulties in localizing effector
proteins after translocation from the bacteria, since they are
usually delivered in very low amounts. Furthermore, the restric-
tions in tag choice and position within the effector protein
imposed by the protein delivery systems themselves have signif-
icantly hampered the development of reliable technologies to
visualize in vivo the delivery and location of the effector proteins
during infection. To add to the challenges, some effector
proteins utilize the same domain to serve as signal for T3S
from the bacteria and to serve as signal for proper localization
within the eukaryotic host cell (Montagna et al., 2001). Some
information on the localization of effectors within cells has
been gleaned by transient expression of tagged forms of the
effectors. However, as discussed above, these types of experi-
ments may lead to artifacts and therefore should be interpreted
with caution. In any case, through limited studies, two common
themes are beginning to emerge in the mechanisms of effector
protein localization.
One mechanism involves specific domains within the effector
protein that serve to target the particular biochemical activity en-
coded in a different domain of the same effector (Rabin et al.,
2006; Schlumberger et al., 2007; Zhang and Barbieri, 2005).
This is a common mechanism that directs the localization and
the activity of many host cellular proteins. Therefore, it is not
surprising that many effectors have domains that share either
primary amino acid sequence or structural similarity to domains
known to target eukaryotic cell proteins. For example, a family of
effector proteins encoded by different pathogens possesses
a leucine-rich repeat domain that, at least in some cases, medi-
ates the localization of their activity to specific locations (Benab-
dillah et al., 2004; Quezada et al., 2009). Leucine-rich repeat
domains, which are in essence ‘‘protein-protein’’ interaction
domains, often serve the same purpose in several eukaryotic
cell proteins. In addition, some effectors possess nuclear local-
ization signals, which allow them to utilize the nuclear import
machinery to reach their final destination (Benabdillah et al.,
2004; Szurek et al., 2002).576 Cell Host & Microbe 5, June 18, 2009 ª2009 Elsevier Inc.Another mechanism of effector localization involves their
‘‘posttranslocation’’ modification within the host cell. In this
case, the effectors make use of cellular machinery to acquire
additional information, which directs them to their specific site
of action. For example, the localization of several T3SS effectors
from the plant pathogen Pseudomonas syringae is mediated by
consensus myristoylation sites, which upon myristoylation inside
the host cell target these effectors to the plasma membrane
(Nimchuk et al., 2000). In addition to serving as a signal for degra-
dation, ubiquitination is also used as a targeting signal for some
effector proteins. Such is the case of the Salmonella effector
SopB, a phosphoinositide phosphatase which, with the same
catalytic activity, mediates bacterial internalization (Zhou et al.,
2001), stimulates the production of nitric oxide (Drecktrah
et al., 2005), activates Akt (Steele-Mortimer et al., 2000), and
modulates vesicular trafficking of the bacteria-containing
vacuole (Hernandez et al., 2004; Mallo et al., 2008). Upon trans-
location from the bacteria, SopB is rapidly monoubiquitinated
(Marcus et al., 2002), which results in its removal from the plasma
membrane and its delivery to the Salmonella-containing vacuole
(SCV) (Patel et al., 2009). In the absence of ubiquitination, SopB
remains at the plasma membrane, where it continues to stimu-
late actin cytoskeleton rearrangements and Akt activation.
However, nonubiquitinated SopB fails to localize to the SCV, re-
sulting in defective intracellular bacterial growth (Patel et al.,
2009). Thus, by exploiting the host ubiquitination machinery,
S. Typhimurium not only properly localizes an effector protein
but also broadens the functional repertoire of a virulence factor
to maximize its ability to modulate cellular functions.
Functional Redundancy
A central element in the design of a robust system is to build
functional redundancy. It is therefore not surprising that T3SSs
have evolved quite a bit of redundancy, particularly regarding
the activities of their effectors. This redundancy takes at least
two forms. The simplest form is exemplified by the presence of
highly related effectors with apparently similar function. There
is, however, a different type of redundancy that is more subtle
and consequently often difficult to identify. This type of redun-
dancy involves effectors that have different biochemical activity
but target a similar cellular process. For example, Yersinia spp.
target Rho family GTPases to prevent phagocytosis through
the activity of at least three different effectors, YopE, YopT,
and YpkA (Trosky et al., 2008). However, although all of these
effectors inhibit Rho family GTPases, they do so by different
mechanisms. As discussed above, YopE is a GAP that potently
inhibits several members of the Rho family. In contrast, YpkA
inhibits Rho GTPases by mimicking host guanidine nucleotide
dissociation inhibitors, thus inhibiting nucleotide exchange in
these GTPases. On the other hand, YopT, a cysteine protease,
exerts its inhibitory effect by removing the prenylated cysteine
from the C terminus of the Rho GTPases, thus releasing them
from membranes and preventing their function.
Another form of redundancy in the targeting of Rho GTPases is
observed in S. Typhimurium. These bacteria stimulate Rho
GTPases to mediate their own uptake into nonphagocytic cells.
They do so through the functionally redundant activity of three
T3SS effector proteins, SopE, SopE2, and SopB. As discussed
above, SopE and SopE2 are GEFs for Rac1, Cdc42, and RhoG
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Review(Hardt et al., 1998a; Stender et al., 2000). SopB, on the other
hand, is a phosphoinositide phosphatase that activates Rho
family GTPases by stimulating the activity of endogenous
exchange factors through the metabolic fluxing of phosphoinosi-
tides (Patel and Gala´n, 2006). Naturally, the built-in redundancy
in T3SSs adds to the difficulties in the study of the function of
individual effector proteins, particularly when the redundancy
is not immediately apparent. Indeed, it is a common occurrence
that elimination of a single effector protein does not lead to
a measurable phenotype, which hampers the study of the role
of a specific effector during infection. The identification and elim-
ination of all the redundant effectors is often required to be able
to observe a phenotype. However, it is also likely that the lack of
phenotypes often observed after the elimination of a single
effector may not be due to redundancy, but rather to the lack
of a specific assay capable of detecting the absence of such
an effector. Therefore, the list of ‘‘redundant effectors’’ is likely
to diminish as we develop more biological assays and learn
more about these systems.
Concluding Remarks
The last few years have seen remarkable progress in the under-
standing of the function of bacterial effector proteins. This knowl-
edge has already revealed common themes in the design and
function of this remarkable family of bacterial virulence factors.
The identification of the biochemical activities of many effector
proteins has not only increased our understanding of these
systems but has also potentially uncovered new basic cell
biology. The challenge for the future remains gaining a better
understanding of the contribution of the different bacterial effec-
tors and the machines that deliver them to the biology and/or
pathogenesis of the different bacteria that harbor them. This
will necessitate the precise definition of the physiologically rele-
vant targets of the different effectors, an area of research that
has lagged behind because of the lack of suitable experimental
tools or model systems. There is now firm evidence that indi-
cates that effector proteins delivered by a given bacterium
work in concert with one another. Therefore, the understanding
of the function of a given protein delivery system as a whole
will require the definition of the function of all or most of the
effector proteins delivered by this particular system. Considering
the fact that a given pathogen delivers multiple effector proteins,
the task ahead is daunting but not less exciting. It is simply
hoped that the next few years will be as exciting and productive
as the last few.
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